• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马其顿 OCRL 突变患儿的临床和实验室特征。

Clinical and laboratory features of Macedonian children with OCRL mutations.

机构信息

University Children's Hospital, Medical School Skopje, Skopje, Macedonia.

出版信息

Pediatr Nephrol. 2011 Apr;26(4):557-62. doi: 10.1007/s00467-010-1758-9. Epub 2011 Jan 20.

DOI:10.1007/s00467-010-1758-9
PMID:21249396
Abstract

OCRL mutations, which are a hallmark of Lowe syndrome, have recently been found in patients with isolated renal phenotype (Dent-2 disease). In this report, we describe clinical and laboratory features in five Macedonian children with mutations in the OCRL gene. Children with a clinical diagnosis of Lowe syndrome or Dent disease underwent complete neurological and ophthalmological examination, imaging of the kidney and urinary tract, assessment of renal tubular function, and mutation analysis of the OCRL gene. Two children (18 months and 11 years, respectively) were diagnosed with Lowe syndrome on the basis of congenital cataracts, severe psychomotor retardation, and renal dysfunction. Both children had low molecular weight proteinuria (LMWP) and hypercalciuria, but not Fanconi syndrome. The older one had bilateral nephrolithiasis due to associated hypocitraturia and mild hyperoxaluria. Three children with asymptomatic proteinuria were diagnosed with Dent-2 disease; none had cataracts or neurological deficit. One child showed mild mental retardation. All had LMWP, hypercalciuria, and elevated enzymes (creatine phosphokinase, lactic dehydrogenase). All three children had an abnormal Tc-99m DMSA scan revealing poor visualization of the kidneys with a high radionuclide content in the bladder; none had nephrolithiasis or nephrocalcinosis. In conclusion, children with OCRL mutations may present with very mild phenotype (asymptomatic proteinuria with/without mild mental retardation) or severe classic oculocerebrorenal syndrome of Lowe. Elevated enzymes and abnormal results on the Tc-99m DMSA scan may be useful indicators for Dent-2 disease.

摘要

OCRL 突变是 Lowe 综合征的一个标志,最近在孤立性肾表型(Dent-2 病)的患者中发现。在本报告中,我们描述了 5 名马其顿儿童 OCRL 基因突变的临床和实验室特征。具有 Lowe 综合征或 Dent 病临床诊断的儿童接受了完整的神经学和眼科检查、肾脏和泌尿道成像、肾小管功能评估以及 OCRL 基因突变分析。两名儿童(分别为 18 个月和 11 岁)基于先天性白内障、严重精神运动发育迟缓以及肾功能障碍被诊断为 Lowe 综合征。两名儿童均有低分子量蛋白尿(LMWP)和高钙尿症,但没有 Fanconi 综合征。年龄较大的儿童因伴发低枸橼酸尿和轻度高草酸尿而出现双侧肾结石。三名无症状蛋白尿儿童被诊断为 Dent-2 病;均无白内障或神经缺陷。一名儿童表现出轻度智力障碍。所有儿童均有 LMWP、高钙尿症和升高的酶(肌酸磷酸激酶、乳酸脱氢酶)。所有三名儿童的 Tc-99m DMSA 扫描均异常,显示肾脏显影不良,膀胱中放射性核素含量高;均无肾结石或肾钙质沉着症。总之,OCRL 突变的儿童可能表现出非常轻微的表型(无症状蛋白尿伴/不伴轻度智力障碍)或 Lowe 经典眼脑肾综合征。升高的酶和 Tc-99m DMSA 扫描异常结果可能是 Dent-2 病的有用指标。

相似文献

1
Clinical and laboratory features of Macedonian children with OCRL mutations.马其顿 OCRL 突变患儿的临床和实验室特征。
Pediatr Nephrol. 2011 Apr;26(4):557-62. doi: 10.1007/s00467-010-1758-9. Epub 2011 Jan 20.
2
OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.OCRL 缺乏症会损害 Lowe 综合征和 Dent 病的人源化小鼠模型中的内溶酶体功能。
Hum Mol Genet. 2019 Jun 15;28(12):1931-1946. doi: 10.1093/hmg/ddy449.
3
Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction.洛氏综合征的肾脏表型:一种选择性近端肾小管功能障碍。
Clin J Am Soc Nephrol. 2008 Sep;3(5):1430-6. doi: 10.2215/CJN.00520108. Epub 2008 May 14.
4
Decreased urinary excretion of the ectodomain form of megalin (A-megalin) in children with OCRL gene mutations.OCRL基因突变儿童中巨膜蛋白胞外域形式(A-巨膜蛋白)的尿排泄减少。
Pediatr Nephrol. 2017 Apr;32(4):621-625. doi: 10.1007/s00467-016-3535-x. Epub 2016 Oct 20.
5
A case of Dent disease type 2 with large deletion of OCRL diagnosed after close examination of a school urinary test.经学校尿检仔细检查后诊断的 Dent 病 2 型伴 OCRL 大片段缺失病例。
CEN Case Rep. 2022 Aug;11(3):366-370. doi: 10.1007/s13730-022-00685-3. Epub 2022 Jan 31.
6
OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.与Lowe综合征细胞相比,Dent-2病患者的OCRL突变成纤维细胞表现出与INPP5B无关的表型变异性。
Hum Mol Genet. 2015 Feb 15;24(4):994-1006. doi: 10.1093/hmg/ddu514. Epub 2014 Oct 9.
7
Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.用于 Lowe 综合征/Dent 病 2 型肾小管病的小鼠模型。
J Am Soc Nephrol. 2011 Mar;22(3):443-8. doi: 10.1681/ASN.2010050565. Epub 2010 Dec 23.
8
Onset mechanism of a female patient with Dent disease 2.一名2型丹特病女性患者的发病机制。
Clin Exp Nephrol. 2020 Oct;24(10):946-954. doi: 10.1007/s10157-020-01926-4. Epub 2020 Jul 14.
9
Identification of novel OCRL isoforms associated with phenotypic differences between Dent disease-2 and Lowe syndrome.鉴定与 Dent 病 2 型和 Lowe 综合征之间表型差异相关的新型 OCRL 异构体。
Nephrol Dial Transplant. 2022 Jan 25;37(2):262-270. doi: 10.1093/ndt/gfab274.
10
Genotype Phenotype Correlation in Dent Disease 2 and Review of the Literature: Gene Pleiotropism or Extreme Phenotypic Variability of Lowe Syndrome?遗传性肾钙质沉着症 2 型的基因型-表型相关性及文献复习:是 Lowe 综合征的基因多效性还是表型极端变异?
Genes (Basel). 2021 Oct 11;12(10):1597. doi: 10.3390/genes12101597.

引用本文的文献

1
Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins.罗氏综合征患者细胞表现出雷帕霉素和他汀类药物可缓解的 mTOR 和 RhoGTPase 依赖性表型。
Hum Mol Genet. 2020 Jun 27;29(10):1700-1715. doi: 10.1093/hmg/ddaa086.
2
The Spectrum of Kidney Diseases in Children Associated with Low Molecular Weight Proteinuria.与低分子量蛋白尿相关的儿童肾脏疾病谱
Open Access Maced J Med Sci. 2018 May 16;6(5):814-819. doi: 10.3889/oamjms.2018.221. eCollection 2018 May 20.
3
Incidental Detection of Dent-2 Disease in an Infant with Febrile Proteinuria.

本文引用的文献

1
Focal segmental glomerulosclerosis in a boy with Dent-2 disease.
Pediatr Nephrol. 2010 Apr;25(4):781-2. doi: 10.1007/s00467-009-1362-z. Epub 2009 Nov 10.
2
Dent's disease manifesting as focal glomerulosclerosis: Is it the tip of the iceberg?Dent 病表现为局灶性肾小球硬化:这只是冰山一角吗?
Pediatr Nephrol. 2009 Dec;24(12):2369-73. doi: 10.1007/s00467-009-1299-2.
3
Locus heterogeneity of Dent's disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations.丹特病的基因座异质性:无CLCN5突变患者中的OCRL1和TMEM27基因
婴儿发热性蛋白尿时偶然发现 Dent-2 病。
Med Princ Pract. 2018;27(4):392-395. doi: 10.1159/000490147. Epub 2018 May 17.
4
Splicing Analysis of Exonic OCRL Mutations Causing Lowe Syndrome or Dent-2 Disease.导致 Lowe 综合征或 Dent-2 病的外显子 OCRL 突变的剪接分析
Genes (Basel). 2018 Jan 4;9(1):15. doi: 10.3390/genes9010015.
5
Proteinuria in Dent disease: a review of the literature.Dent 病中的蛋白尿:文献综述。
Pediatr Nephrol. 2017 Oct;32(10):1851-1859. doi: 10.1007/s00467-016-3499-x. Epub 2016 Oct 18.
6
The oculocerebrorenal syndrome of Lowe: an update.洛氏眼脑肾综合征:最新进展。
Pediatr Nephrol. 2016 Dec;31(12):2201-2212. doi: 10.1007/s00467-016-3343-3. Epub 2016 Mar 24.
7
Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis.小儿肾结石或肾钙质沉着症患者单基因病因的患病率。
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):664-72. doi: 10.2215/CJN.07540715. Epub 2016 Jan 19.
8
Muscle involvement in Dent disease 2.肌肉受累于丹特病2型。
Pediatr Nephrol. 2014 Nov;29(11):2127-32. doi: 10.1007/s00467-014-2841-4. Epub 2014 Jun 7.
9
Novel OCRL mutations in Chinese children with Lowe syndrome.中国人 Lowe 综合征患儿中新的 OCRL 突变。
World J Pediatr. 2013 Feb;9(1):53-7. doi: 10.1007/s12519-013-0406-4. Epub 2013 Feb 7.
10
A novel and de novo deletion in the OCRL1 gene associated with a severe form of Lowe syndrome.一个新的、从头缺失的 OCRL1 基因突变与 Lowe 综合征的严重形式有关。
Int Urol Nephrol. 2013 Dec;45(6):1767-71. doi: 10.1007/s11255-012-0246-5. Epub 2012 Jul 21.
Pediatr Nephrol. 2009 Oct;24(10):1967-73. doi: 10.1007/s00467-009-1228-4. Epub 2009 Jul 7.
4
Decreased renal uptake of (99m)Tc-DMSA in patients with tubular proteinuria.肾小管蛋白尿患者中(99m)Tc-DMSA肾摄取减少。
Pediatr Nephrol. 2009 Nov;24(11):2211-6. doi: 10.1007/s00467-009-1238-2. Epub 2009 Jul 5.
5
Dent-2 disease: a mild variant of Lowe syndrome.登特2型疾病:洛氏综合征的一种轻度变体。
J Pediatr. 2009 Jul;155(1):94-9. doi: 10.1016/j.jpeds.2009.01.049.
6
OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability.丹特2型患者中的OCRL1突变提示了一种表型变异性的机制。
Nephron Physiol. 2009;112(2):p27-36. doi: 10.1159/000213506. Epub 2009 Apr 18.
7
Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction.洛氏综合征的肾脏表型:一种选择性近端肾小管功能障碍。
Clin J Am Soc Nephrol. 2008 Sep;3(5):1430-6. doi: 10.2215/CJN.00520108. Epub 2008 May 14.
8
Renal manifestations of Dent disease and Lowe syndrome.丹特病和洛氏综合征的肾脏表现。
Pediatr Nephrol. 2008 Feb;23(2):243-9. doi: 10.1007/s00467-007-0686-9. Epub 2007 Nov 24.
9
A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway.洛氏综合征蛋白OCRL在内吞途径早期步骤中的作用。
Dev Cell. 2007 Sep;13(3):377-90. doi: 10.1016/j.devcel.2007.08.004.
10
OCRL1 mutations in patients with Dent disease phenotype in Japan.日本具有丹特病表型患者中的OCRL1突变
Pediatr Nephrol. 2007 Jul;22(7):975-80. doi: 10.1007/s00467-007-0454-x. Epub 2007 Mar 24.